|
|
||||||||
Biology of Reproduction, Vol 15, 329-334, Copyright © 1976 by Society for the Study of Reproduction
1 From the Division of Pediatric Surgery and the
Pediatric Surgical Research Laboratory, Massachusetts General Hospital,
Department of Surgery, Harvard Medical School,
Boston, Massachusetts 02114 The secretory pattern of Mullerian Inhibiting Substance in the rat was documented by a graded
organ culture assay on each day of the perinatal period and at more widely spaced intervals in the
adult period. The influence of placenta and pituitary on Mullerian Inhibiting Substance production
was studied. Fetal testicular fragments were displaced from target Mullerian ducts to determine if
Mullerian Inhibiting Substance would act at a distance. Rat testes produced Mullerian Inhibiting Substance throughout the latter third of gestation. Its
production continued during the first three weeks of extrauterine life, after which it disappeared,
coincident with weaning. Hypophysectomy carried out after 20 days of age was ineffective in
restoring Mullerian Inhibiting Substance activity to the adult rat testis. Placental fragments neither
prolonged nor enhanced the Mullerian Inhibiting Substance activity of perinatal testes in organ
culture. Mullerian Inhibiting Substance exerted its regressive effect on Mullerian ducts placed at a
distance from a testicular source.
Note:
ACKNOWLEDGMENT
The authors acknowledge helpful discussions and
continued interest of John F. Enders, John D.
Crawford, David A. Swann, and J. Micheal Price.
This article has been cited by other articles:
![]() |
X. Wu, S. Wan, S. Pujar, M. E. Haskins, D. H. Schlafer, M. M. Lee, and V. N. Meyers-Wallen A Single Base Pair Mutation Encoding a Premature Stop Codon in the MIS Type II Receptor Is Responsible for Canine Persistent Mullerian Duct Syndrome J Androl, January 1, 2009; 30(1): 46 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Szotek, R. Pieretti-Vanmarcke, P. T. Masiakos, D. M. Dinulescu, D. Connolly, R. Foster, D. Dombkowski, F. Preffer, D. T. MacLaughlin, and P. K. Donahoe Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness PNAS, July 25, 2006; 103(30): 11154 - 11159. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Teixeira, S. Maheswaran, and P. K. Donahoe Mullerian Inhibiting Substance: An Instructive Developmental Hormone with Diagnostic and Possible Therapeutic Applications Endocr. Rev., October 1, 2001; 22(5): 657 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Watanabe, T. R. Clarke, A. H. Lane, X. Wang, and P. K. Donahoe Endogenous expression of Mullerian inhibiting substance in early postnatal rat Sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites PNAS, February 15, 2000; 97(4): 1624 - 1629. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Rouiller-Fabre, S. Carmona, R. A. Merhi, R. Cate, R. Habert, and B. Vigier Effect of Anti-Mullerian Hormone on Sertoli and Leydig Cell Functions in Fetal and Immature Rats Endocrinology, March 1, 1998; 139(3): 1213 - 1220. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |